A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis

Author: Kasper Lloyd H.   Everitt Daniel   Leist Thomas P.   Ryan Kathleen A.   Mascelli Mary Ann   Johnson Kenneth   Raychaudhuri Aparna   Vollmer Tim    

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.22, Iss.9, 2006-09, pp. : 1671-1678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content